Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
964
Views
41
CrossRef citations to date
0
Altmetric
Research Article

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment

Sabina ChiarettiDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Marilisa MarinelliDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Ilaria Del GiudiceDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Silvia BoninaDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Alfonso PiciocchiGIMEMA Data Center, GIMEMA Foundation, Rome, Italy
,
Monica MessinaDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Marco VignettiDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy;GIMEMA Data Center, GIMEMA Foundation, Rome, Italy
,
Davide RossiDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
,
Valeria Di MaioDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Francesca Romana MauroDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Anna GuariniDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
,
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
&
Robin FoàDivision of Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, ItalyCorrespondence[email protected] [email protected]
 show all
Pages 2785-2792 | Received 04 Nov 2013, Accepted 07 Feb 2014, Published online: 06 Mar 2014

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Rupal Tripathi, Eriong Lee-Verges, Morihiro Higashi, Neus Gimenez, Laia Rosich, Monica Lopez-Guerra & Dolors Colomer. (2017) New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia. Expert Opinion on Drug Discovery 12:10, pages 1041-1052.
Read now
Manli Jiang, N. Nora Bennani & Andrew L. Feldman. (2017) Lymphoma classification update: B-cell non-Hodgkin lymphomas. Expert Review of Hematology 10:5, pages 405-415.
Read now
Paula Díez, Rafael Góngora, Alberto Orfao & Manuel Fuentes. (2017) Functional proteomic insights in B-cell chronic lymphocytic leukemia. Expert Review of Proteomics 14:2, pages 137-146.
Read now

Articles from other publishers (38)

Prajish Iyer & Lili Wang. (2023) Emerging Therapies in CLL in the Era of Precision Medicine. Cancers 15:5, pages 1583.
Crossref
Bella V. Biderman, Ekaterina B. Likold, Nataliya A. Severina, Tatiana N. Obukhova & Andrey B. Sudarikov. (2023) Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors. Genes 14:2, pages 532.
Crossref
Lauren M. Wainman, Wahab A. Khan & Prabhjot Kaur. 2022. Advancements in Cancer Research. Advancements in Cancer Research 93 106 .
Federico Pozzo, Tamara Bittolo, Erika Tissino, Antonella Zucchetto, Riccardo Bomben, Laura Polcik, Svenja Dannewitz Prosseda, Tanja Nicole Hartmann & Valter Gattei. (2022) Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond. Cancers 14:12, pages 2997.
Crossref
Thomas A. Burley, Emma Kennedy, Georgia Broad, Melanie Boyd, David Li, Timothy Woo, Christopher West, Eleni E. Ladikou, Iona Ashworth, Christopher Fegan, Rosalynd Johnston, Simon Mitchell, Simon P. Mackay, Andrea G. S. Pepper & Chris Pepper. (2022) Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma. Cancers 14:6, pages 1489.
Crossref
Raffaele Frazzi. (2021) BIRC3 and BIRC5: multi‐faceted inhibitors in cancer. Cell & Bioscience 11:1.
Crossref
Maciej Putowski & Krzysztof Giannopoulos. (2021) Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3. Journal of Clinical Medicine 10:16, pages 3735.
Crossref
Katerina Katsaraki, Panagiotis G. Adamopoulos, Sotirios G. Papageorgiou, Vasiliki Pappa, Andreas Scorilas & Christos K. Kontos. (2021) A 3′ tRNA‐derived fragment produced by tRNA LeuAAG and tRNA LeuTAG is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors . European Journal of Haematology 106:6, pages 821-830.
Crossref
Yi Ding. 2021. Practical Oncologic Molecular Pathology. Practical Oncologic Molecular Pathology 339 359 .
Paraskevi Karousi, Panagiotis G. Adamopoulos, Sotirios G. Papageorgiou, Vasiliki Pappa, Andreas Scorilas & Christos K. Kontos. (2020) A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia. Clinical Biochemistry 85, pages 20-26.
Crossref
Jimmy Lee & Y. Lynn Wang. (2020) Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia. The Journal of Molecular Diagnostics 22:9, pages 1114-1125.
Crossref
Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Giovanni Del Poeta, Annalisa Biagi, Luca Laurenti, Annalisa Chiarenza, Federico Pozzo, Idanna Innocenti, Massimiliano Postorino, Francesca Maria Rossi, Maria Ilaria Del Principe, Riccardo Bomben, Paolo de Fabritiis, Antonio Bruno, Maria Cantonetti, Francesco Di Raimondo, Antonella Zucchetto & Valter Gattei. (2020) Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia. Haematologica 106:9, pages 2345-2353.
Crossref
Catherine Hoofd, Steven J. Huang, Samuel Gusscott, Sonya Lam, Rachel Wong, Alexa Johnston, Susana Ben-Neriah, Christian Steidl, David W. Scott, Helene Bruyere, Tanya L. Gillan, Cynthia L. Toze, Alina S. Gerrie & Andrew P. Weng. (2020) Ultrasensitive Detection of NOTCH1 c.7544_7545delCT Mutations in Chronic Lymphocytic Leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts Clinical Outcome in Cases with Trisomy 12. The Journal of Molecular Diagnostics 22:4, pages 571-578.
Crossref
Fatima Mrkulić, Lejla Gurbeta, Enisa Omanović-Mikličanin, Tamer Bego, Berina Hasanefendić & Almir Badnjević. 2020. CMBEBIH 2019. CMBEBIH 2019 597 603 .
Jennifer L. Crombie, Anthony Letai & John G. Gribben. 2019. Molecular Hematology 4e. Molecular Hematology 4e 101 110 .
Jennifer L. Crombie & Jennifer R. Brown. (2019) Advances in drug‐based therapies in chronic lymphocytic leukemia and future prospects. ADVANCES IN CELL AND GENE THERAPY 2:3.
Crossref
Michaela Spunarova, Nikola Tom, Sarka Pavlova, Marek Mraz, Yvona Brychtova, Michael Doubek, Anna Panovska, Hana Skuhrova Francova, Anna Brzobohata, Sarka Pospisilova, Jiri Mayer & Martin Trbusek. (2019) Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. Leukemia Research 81, pages 75-81.
Crossref
Gerardo Ferrer & Emili Montserrat. (2018) Critical molecular pathways in CLL therapy. Molecular Medicine 24:1.
Crossref
Kathy Chun, Gail D. Wenger, Alka Chaubey, D.P. Dash, Rashmi Kanagal-Shamanna, Sibel Kantarci, Ravindra Kolhe, Daniel L. Van Dyke, Lu Wang, Daynna J. Wolff & Patricia M. Miron. (2018) Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genetics 228-229, pages 236-250.
Crossref
Kalpana S. Reddy & Keyur P. Patel. (2018) Genomic Biomarkers in Pathogenesis and Clinical Care of Chronic Lymphocytic Leukemia. Advances in Molecular Pathology 1:1, pages 51-64.
Crossref
Andrew Paul, Joanne Edwards, Christopher Pepper & Simon Mackay. (2018) Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets. Cells 7:10, pages 176.
Crossref
Emanuela Rosati, Stefano Baldoni, Filomena De Falco, Beatrice Del Papa, Erica Dorillo, Chiara Rompietti, Elisa Albi, Franca Falzetti, Mauro Di Ianni & Paolo Sportoletti. (2018) NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. Frontiers in Oncology 8.
Crossref
Tiziana Vaisitti, Francesca Arruga & Silvia Deaglio. (2018) Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?. International Journal of Molecular Sciences 19:4, pages 1167.
Crossref
Prajwal Boddu & Alessandra Ferrajoli. (2018) Prognostic Factors in the Era of Targeted Therapies in CLL. Current Hematologic Malignancy Reports 13:2, pages 78-90.
Crossref
Stacy S. Hung, Barbara Meissner, Elizabeth A. Chavez, Susana Ben-Neriah, Daisuke Ennishi, Martin R. Jones, Hennady P. Shulha, Fong Chun Chan, Merrill Boyle, Robert Kridel, Randy D. Gascoyne, Andrew J. Mungall, Marco A. Marra, David W. Scott, Joseph M. Connors & Christian Steidl. (2018) Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management. The Journal of Molecular Diagnostics 20:2, pages 203-214.
Crossref
Prabhjot KaurPrabhjot Kaur. 2018. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 35 60 .
Arantza Onaindia, L Jeffrey Medeiros & Keyur P Patel. (2017) Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. Modern Pathology 30:10, pages 1338-1366.
Crossref
Véronique Imbert & Jean-François Peyron. (2017) NF-κB in Hematological Malignancies. Biomedicines 5:2, pages 27.
Crossref
Thomas Sau-Yan Chan, Yuh-Shan Lee, Ilaria Del Giudice, Marilisa Marinelli, Caterina Ilari, Luciana Cafforio, Anna Guarini, Daryl Tan, Colin Phipps, Yeow-Tee Goh, William Hwang, Allan Zhi-Kai Goh, Lisa Lai-Ping Siu, Saliangi Wu, Chun-Yin Ha, Shek-Ying Lin, Chi-Hang Kwok, Chi-Kuen Lau, Kit-Fai Wong, Robin Foà, Yok-Lam Kwong & Eric Tse. (2017) Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients. Oncotarget 8:15, pages 25455-25468.
Crossref
Larry Mansouri, Nikos Papakonstantinou, Stavroula Ntoufa, Kostas Stamatopoulos & Richard Rosenquist. (2016) NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions. Seminars in Cancer Biology 39, pages 40-48.
Crossref
Emili Montserrat, Tycho Bauman & Julio Delgado. (2016) Present and future of personalized medicine in CLL. Best Practice & Research Clinical Haematology 29:1, pages 100-110.
Crossref
Carlos I. Amaya-Chanaga & Laura Z. Rassenti. (2016) Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers. Best Practice & Research Clinical Haematology 29:1, pages 79-89.
Crossref
Kanti R. Rai & Preetesh Jain. (2016) Chronic lymphocytic leukemia (CLL)-Then and now. American Journal of Hematology 91:3, pages 330-340.
Crossref
Gian Matteo Rigolin, Ilaria del Giudice, Luca Formigaro, Elena Saccenti, Sara Martinelli, Maurizio Cavallari, Enrico Lista, Elisa Tammiso, Eleonora Volta, Laura Lupini, Cristian Bassi, Antonella Bardi, Olga Sofritti, Giulia Daghia, Francesco Cavazzini, Marilisa Marinelli, Simona Tavolaro, Anna Guarini, Massimo Negrini, Robin Fo? & Antonio Cuneo. (2015) Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. Genes, Chromosomes and Cancer 54:12, pages 818-826.
Crossref
Carol Lozano-Santos, Irene Amigo-Jim?nez, Sara Nova-Gurumeta, Nuria P?rez-Sanz, Angeles Garc?a-Pardo & Jos? A. Garc?a-Marco. (2015) Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathways. Biochemical and Biophysical Research Communications 461:2, pages 243-248.
Crossref
David Rodríguez, Gabriel Bretones, Javier R. Arango, Víctor Valdespino, Elías Campo, Víctor Quesada & Carlos López-Otín. (2015) Molecular pathogenesis of CLL and its evolution. International Journal of Hematology 101:3, pages 219-228.
Crossref
Clare Sun & Adrian Wiestner. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 147 175 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.